False Claims Act Insights

Jonathan Porter
  • 5.0 (4)
  • BUSINESS
  • UPDATED MONTHLY

False Claims Act Insights explores how the U.S. government uses the False Claims Act (FCA) to stamp out fraud and corruption in government contracts. Each episode, Jonathan Porter, a former Assistant U.S. Attorney and currently a partner with Husch Blackwell’s White Collar, Internal Investigations & Compliance team, chats with preeminent guests to provide listeners with an up-to-date understanding of the FCA, including trends in recent litigation and compliance efforts. The show also explores those elements of the FCA that make it a uniquely powerful tool for the government against private business, including the Act’s utilization of whistleblowers and its qui tam provisions, as well as evolving theories of FCA liability that expand the boundaries of what the Act covers, including cybersecurity and so-called reverse FCA claims.

  1. 5H AGO

    Healthcare Compensation and Referrals: Avoiding Compliance Pitfalls in Physician Deals

    Host Jonathan Porter welcomes Husch Blackwell’s Hal Katz back to the podcast to discuss best practices for structuring physician compensation arrangements and navigating the complex compliance landscape surrounding healthcare referrals. Fresh off presenting at the American Association of Orthopaedic Executives (AAOE) conference, Hal and Jonathan share insights on how healthcare organizations can align financial incentives while staying on the right side of Stark Law and False Claims Act requirements. We begin by examining the spectrum of compliance violations in physician compensation arrangements, from blatant criminal schemes designed to “buy surgeries” through sham consulting contracts to more nuanced cases where well-intentioned financial teams make statements about downstream benefits that later appear in DOJ complaints. Hal discusses a recent DOJ Stark intervention against a Tennessee health system and provides practical guidance on what healthcare executives and compliance officers should and should not say during physician compensation discussions. Next, we turn to the mechanics of how compensation is calculated, drawing lessons from major cases like Tuomey and a Florida hospital settlement where the formula itself included problematic metrics. Hal explains the risks of “black box” compensation arrangements and offers best practices for creating transparent, defensible methodologies that can withstand government scrutiny. Our conversation then shifts to private equity investment in healthcare and the tension between financial realities and compliance requirements. We discuss industry terms like “leakage” and “keeping procedures,” examining how organizations can have honest conversations about referral patterns without crossing legal lines. We close with actionable compliance recommendations. Hal outlines concrete steps that executives, compliance officers, and physician group leaders can take today to strengthen their guardrails and build sustainable, defensible business practices in an increasingly scrutinized industry.  Jonathan Porter | Full Biography Jonathan focuses on white collar criminal defense, federal investigations brought under the False Claims Act, and litigation against the government and whistleblowers. He draws on his experience as a former federal prosecutor to guide clients in sensitive and enterprise-threatening litigation. At the Department of Justice, Jonathan earned a reputation as a top white-collar prosecutor and trial lawyer and was a key member of multiple international healthcare fraud takedowns and high-profile financial crime prosecution teams. He serves as a vice chair of the American Health Law Association’s Fraud and Abuse Practice Group and teaches white collar crime as an adjunct professor of law at Mercer University School of Law. Hal Katz | Full Biography Based in Austin, Texas, Hal provides healthcare clients with guidance on corporate, transactional, regulatory, and public policy matters. With over 30 years in practice, he has witnessed firsthand the evolution of the healthcare industry that continues to reshape the business and approaches of healthcare delivery. He represents for-profit, nonprofit, and governmental entities, including medical groups, hospitals, technology companies, behavioral health organizations, private equity funds, academic medical centers, and health plans. Since 2011, Hal has served the American Bar Association’s Health Law Section in a variety of leadership posts— including as its Chair from 2020 to 2021. Additionally, from 2017 to 2018, he chaired the Health Law Section of the State Bar of Texas. Hal also serves on the Board of Trustees of Integral Care and on the Board of the Texas e-Health Alliance, where his work focuses on governance, policy, and the responsible use of technology in healthcare.

    16 min

  2. MAR 30

    $1.6 Billion FCA Judgment on Appeal: What it Means for FCA Enforcement

    Host Jonathan Porter welcomes Husch Blackwell’s Abe Souza to the podcast to discuss the recent oral arguments in the Janssen Products case before the Third Circuit Court of Appeals. The case involves a previously discussed staggering $1.6 billion district court judgment against the pharmaceutical company based on allegations of improper off-label marketing and reimbursement practices related to HIV medications. We begin by examining the massive penalties at stake and the Excessive Fines Clause concerns raised by Janssen’s appeal. Our discussion explores how courts analyze whether False Claims Act penalties are constitutionally excessive, including the facts courts consider when evaluating whether a multi-billion-dollar judgment violates the Eighth Amendment’s protections against excessive fines. Next, we turn to the substantive False Claims Act issues in the case, focusing on whether off-label marketing can serve as a proper predicate for False Claims Act liability. We discuss how the government connects marketing practices to false claims for reimbursement and examine the legal theories that link promotional activities to allegedly fraudulent billing submissions. Our conversation then shifts to the broader constitutional questions presented in the appeal, including challenges to how the False Claims Act is being applied in pharmaceutical cases. We analyze the arguments raised during oral arguments and what they signal about potential limits on False Claims Act enforcement in the healthcare industry. We close by discussing what the Third Circuit’s eventual decision could mean for pharmaceutical companies, healthcare providers, and False Claims Act enforcement more broadly, particularly with respect to the scope of liability for marketing practices and the constitutional boundaries of FCA penalties.  Jonathan Porter | Full Biography Jonathan focuses on white collar criminal defense, federal investigations brought under the False Claims Act, and litigation against the government and whistleblowers. He draws on his experience as a former federal prosecutor to guide clients in sensitive and enterprise-threatening litigation. At the Department of Justice, Jonathan earned a reputation as a top white-collar prosecutor and trial lawyer and was a key member of multiple international healthcare fraud takedowns and high-profile financial crime prosecution teams. He serves as a vice chair of the American Health Law Association’s Fraud and Abuse Practice Group and teaches white collar crime as an adjunct professor of law at Mercer University School of Law. Abe Souza | Full Biography Abe regularly represents clients embroiled in internal and government investigations, as well as in government enforcement actions. He also represents clients in complex business disputes and commercial litigation matters, including those involving antitrust and class action claims. Prior to joining Husch Blackwell, Abe served for nearly five years as an Assistant U.S. Attorney in the Northern District of Illinois where he worked directly with FBI agents and other investigators and served as a first-chair trial lawyer. He began his legal career as a law clerk for the Honorable Joan Humphrey Lefkow of the U.S. District Court for the Northern District of Illinois.

    22 min

  3. MAR 18

    Qui Tam Dismissals Are Spiking: What That Means for FCA Enforcement

    Host Jonathan Porter welcomes Husch Blackwell’s Tanner Cook back to the podcast to discuss the recent spike of DOJ dismissals of improper qui tams under 31 U.S.C. § 3730(c)(2)(A). This episode is a follow-up of our last podcast, in which Husch Blackwell partner Cormac Conner discussed how qui tam dismissals increased by around 400% in 2025.  We begin by addressing common misconceptions about how DOJ views its dismissal power, with its focus on process abuse rather than merit disputes. Next, we examine the Granston Memo, which outlines the Department of Justice's protocols for considering dismissal of qui tam actions on various grounds.  Tanner then walks listeners through the details of considerations DOJ uses to assess qui tams for dismissal potential, with examples of the types of instances where DOJ has exercised its (c)(2)(A) dismissal power in the past. We end the discussion by examining what those who defend False Claims Act investigations and qui tams can learn from these recent developments and how to structure dismissal requests to maximize changes of DOJ action. Jonathan Porter | Full Biography Jonathan focuses on white collar criminal defense, federal investigations brought under the False Claims Act, and litigation against the government and whistleblowers. He draws on his experience as a former federal prosecutor to guide clients in sensitive and enterprise-threatening litigation. At the Department of Justice, Jonathan earned a reputation as a top white-collar prosecutor and trial lawyer and was a key member of multiple international healthcare fraud takedowns and high-profile financial crime prosecution teams. He serves as a vice chair of the American Health Law Association’s Fraud and Abuse Practice Group and teaches white collar crime as an adjunct professor of law at Mercer University School of Law. Tanner Cook | Full Biography Based in St. Louis, Tanner is a member of Husch Blackwell’s Commercial Litigation group, focusing on consumer class actions, antitrust litigation, and multidistrict litigation. He frequently takes the lead in drafting critical pretrial briefs, including dispositive motions and evidentiary challenges. In addition to his commercial litigation practice, Tanner regularly assists on white collar defense matters, especially in the False Claims Act context. He has significant experience defending companies from qui tam whistleblower suits at every stage of the litigation process, combining his deep substantive knowledge of the law with creative defense strategies. Tanner served as law clerk at the U.S. District Court, Eastern District of Missouri, for Judge Sarah E. Pitlyk.

    25 min

  4. FEB 23

    DOJ Announces Record Number of Qui Tams and Qui Tam Dismissals

    Host Jonathan Porter welcomes Husch Blackwell partner Cormac Conner back to the podcast to discuss DOJ’s recent release of last fiscal year’s False Claims Act statistics, along with recent public statements by a senior DOJ official who oversees False Claims Act enforcement. DOJ’s statistics and public statements show that qui tams are hitting record numbers and DOJ is taking a much more active approach to dismissing improper qui tams.  Our conversation starts by examining how DOJ’s statistics signal increased scrutiny of the healthcare and defense contracting industries, with a growing role of qui tams. We look at how DOJ uses the False Claims Act to address the Trump Administration’s policy priorities in the areas of DEI and tariffs enforcement, along with healthcare claims that involve substandard patient care. We then move on to discuss how DOJ’s statistics and public statements led to several major approaching legal battles, including the constitutionality of qui tams and DOJ’s use of artificial intelligence in vetting False Claims Act theories. We close the conversation by focusing on what those in False Claims Act-enforced industries should do to prepare for the growing number of qui tams and False Claims Act investigations. Jonathan Porter | Full Biography Jonathan focuses on white collar criminal defense, federal investigations brought under the False Claims Act and litigation against the government and whistleblowers. He guides clients in sensitive and enterprise-threating litigation, drawing on his experience as a former federal prosecutor. At the Department of Justice, Jonathan earned a reputation as a top white-collar prosecutor and trial lawyer and was a key member of multiple international healthcare fraud takedowns and high-profile financial crime prosecution teams. He serves as a vice chair of the American Health Law Association’s Fraud and Abuse Practice Group and teaches white collar crime as an adjunct professor of law at Mercer University School of Law. Cormac Conner | Full Biography A partner with Husch Blackwell based in Washington, D.C., Cormac has two decades of experience with high-stakes litigation and investigations, both as a prosecutor and as defense counsel. He has advised dozens of clients facing criminal and civil investigations involving all manner of federal criminal investigations, False Claims Act allegations, antitrust allegations, and Foreign Corrupt Practices Act claims. Cormac regularly assists clients with responses to formal and informal investigative inquiries, including Grand Jury subpoenas, Office of Inspector General subpoenas, civil investigative demands, and 28 U.S.C. § 1782 subpoenas. Between his stints in private practice, Cormac was an Assistant U.S. Attorney for nearly four years in the U.S. Attorney’s Office for the District of Columbia, serving as lead prosecutor in 24 criminal trials. In that role, he investigated hundreds of criminal cases, managed Grand Jury investigations, and coordinated investigative activities by law enforcement personnel.

    33 min

  5. FEB 2

    Rogue Employees: Vicarious Liability Under the False Claims Act

    Host Jonathan Porter welcomes back Husch Blackwell partner Lorinda Holloway to the podcast to discuss how organizations become liable for false claims by their employees. We begin by discussing how vicarious liability holds employers responsible for employees' actions, though this principle does not always apply directly to punitive laws like the False Claims Act.  We talk about the courts’ two approaches to False Claims Act vicarious liability, including the Grand Union case, in which the Eleventh Circuit Court of Appeals held a company liable for the isolated improper acts of low-level employees, even though no one in management knew false claims were being submitted. We also discuss the rationale behind decisions like Grand Union, including incentivizing companies to develop compliance systems to stop low-level employees from doing improper things. Our discussion shifts to a series of cases that disagree with Grand Union. These cases state that if the government seeks to recover an amount much greater than its actual losses, then an employer cannot be held vicariously liable under the FCA for wrongful actions carried out by a non-managerial employee—unless the employer was aware of, approved, or acted recklessly regarding the hiring or supervision of that employee. We close the discussion by examining why courts struggle with applying vicarious liability concepts to the False Claims Act and what companies can do to mitigate potential liability for the acts of rogue employees.  Jonathan Porter | Full Biography Jonathan focuses on white collar criminal defense, federal investigations brought under the False Claims Act, and litigation against the government and whistleblowers, drawing on his experience as a former federal prosecutor to guide clients in sensitive and enterprise-threatening litigation. At the Department of Justice, Jonathan earned a reputation as a top white-collar prosecutor and trial lawyer and was a key member of multiple international healthcare fraud takedowns and high-profile financial crime prosecution teams. He serves as a vice chair of the American Health Law Association’s Fraud and Abuse Practice Group and teaches white collar crime as an adjunct professor of law at Mercer University School of Law. Lorinda Holloway | Full Biography Based in Austin, Texas, Lorinda is a member of Husch Blackwell’s Healthcare, Life Sciences and Education industry team and counsels clients on matters concerning government investigations and disputes. For more than 25 years, she has advised and represented clients in and out of the courtroom with a particular focus on the healthcare industry, including False Claims Act, Texas Medicaid Fraud Prevention Act, and qui tam related investigations and lawsuits, audits, as well as business disputes in state and federal court. Lorinda’s experience in healthcare has also led to the education field, including a focus on the legal challenges faced in academic medicine.

    16 min

  6. JAN 12

    The Rise of State False Claims Act Enforcement

    Host Jonathan Porter welcomes Husch Blackwell partners Rebecca Furdek and Todd Gee back to the podcast to discuss the growing amount of enforcement under various state-level False Claims Acts, and the recent Risk Management Magazine article that Rebecca and Todd have written on the subject. Our conversation starts with an overview of state False Claims Acts and how the use of FCA varies from state to state. We examine recent settlements in Massachusetts and Minnesota that show the reach of state False Claims Acts and discuss a large District of Columbia False Claims Act settlement for tax liability that could be the next big enforcement area for state-level False Claims Acts. Our conversation then turns to how states have traditionally focused FCA enforcement on Medicaid claims but are broadening their FCA laws to reach new types of government claims. We discuss how California, for example, is considering a new law that would allow false claims relating to tax to be enforceable under the California False Claims Act. We also talk about how State Attorneys General are likely to play a huge role in using their state FCAs to enforce things that may not gain traction with federal authorities. We conclude with a discussion of what might happen next, and how those doing business with multiple states should track what is enforceable under each state’s FCA. We look at how a robust compliance program should be every company’s first line of defense against FCA liability by finding and fixing issues before they result in FCA problems. Jonathan Porter | Full Biography Jonathan focuses on white collar criminal defense, federal investigations brought under the False Claims Act, and litigation against the government and whistleblowers. He advises clients on sensitive and enterprise-threatening litigation, drawing on his experience as a former federal prosecutor. At the Department of Justice, Jonathan earned a reputation as a top white-collar prosecutor and trial lawyer and was a key member of multiple international healthcare fraud takedowns and high-profile financial crime prosecution teams. He serves as a vice chair of the American Health Law Association’s Fraud and Abuse Practice Group and teaches white collar crime as an adjunct professor of law at Mercer University School of Law. Rebecca Furdek | Full Biography A partner in Husch Blackwell’s Milwaukee office, Rebecca is a member of the firm’s White Collar, Internal Investigations & Compliance team and regularly helps clients navigate today’s regulatory and government enforcement landscape. Before joining Husch, Rebecca served as Counsel to the Solicitor at the U.S. Department of Labor (DOL), where she gained firsthand insight into federal agency rulemaking and administrative enforcement. Prior to her government service, she worked as an associate in the Washington, D.C. office of a global law firm, focusing on litigation and government enforcement, and began her legal career as a judicial law clerk at the U.S. District Court for the Northern District of Texas. During law school, Rebecca served as a law clerk with the U.S. Senate Judiciary Committee. Todd Gee | Full Biography Based in Washington, Todd is a former United States Attorney and experienced trial lawyer who represents businesses and individuals in complex criminal defense, corporate fraud investigations, and regulatory compliance matters. With years of experience as a federal prosecutor and counsel to a congressional committee, he is well-positioned to help clients navigate high-stake and sensitive issues. Todd specializes in guiding them through multifaceted investigations involving overlapping risks posed by criminal investigators, civil litigants, regulatory agencies, or congressional inquiries.

    26 min

  7. 12/16/2025

    The Latest on Zafirov and the Future of Qui Tams

    Host Jonathan Porter welcomes Husch Blackwell partner Jody Rudman back to the podcast to discuss recent oral arguments in an appeal into whether the False Claims Act’s qui tam provisions are unconstitutional. Our conversation starts with an overview of qui tams and the role whistleblowers play in the False Claims Act litigation process. We examine the unique role that whistleblowers can play—standing in the shoes of the government and litigating as though they are the government—and how that differs from other whistleblower programs run by the federal government. Our conversation then turns to the case of United States ex rel. Zafirov v. Florida Medical Associates, LLC, in which a federal judge ruled that qui tams are unconstitutional. We discuss the judge’s constitutional concerns with qui tams in that opinion. We also examine how Zafirov has been appealed to the Eleventh Circuit Court of Appeals, where a three-judge panel heard argument on December 12, 2025, on whether qui tams are indeed unconstitutional. Our discussion analyzes the questions asked by the three-judge panel and how those questions might inform the direction the court takes. We conclude with a discussion of what might happen next, and how other circuits have similar cases pending that call into question the qui tam provision of the False Claims Act. We look at how these cases might make their way to the U.S. Supreme Court and their potential impact on False Claims Act enforcement. Jonathan Porter | Full Biography Jonathan focuses on white collar criminal defense, federal investigations brought under the False Claims Act, and litigation against the government and whistleblowers, using his experience as a former federal prosecutor to guide clients in sensitive and enterprise-threatening litigation. At the Department of Justice, Jonathan earned a reputation as a top white-collar prosecutor and trial lawyer and was a key member of multiple international healthcare fraud takedowns and high-profile financial crime prosecution teams. He serves as a vice chair of the American Health Law Association’s Fraud and Abuse Practice Group and teaches white collar crime as an adjunct professor of law at Mercer University School of Law. Jody Rudman | Full Biography Jody serves as the Office Managing Partner for Husch Blackwell’s Austin office and leads the firm’s White Collar, Internal Investigations & Compliance practice group. She also heads up the firm’s False Claims Act working group. Jody has assisted clients across a wide range of industries with investigations, negotiations, mediations, pretrial matters, grand jury proceedings, civil lawsuits, criminal indictments, jury trials, sentencings, and appeals. She has tried dozens of jury and bench trials in the federal and state courts, argued before the U.S. Court of Appeals for the Fifth Circuit, and appeared before the U.S. Supreme Court. Prior to entering private practice, Jody served as a federal prosecutor for the Northern District of Texas and was appointed by the Texas Attorney General to spearhead high-profile charitable trust and healthcare litigation matters for the State of Texas.

    22 min

  8. 11/18/2025

    Understanding HIPAA Disclosures When Responding to CIDs in FCA Investigations

    Jonathan Porter welcomes colleague Claire Postman to discuss how healthcare providers approach HIPAA when responding to civil investigative demands in False Claims Act investigations. Jonathan explains that providers often feel tension between meeting the requirements of a CID and complying with HIPAA. Claire begins by outlining HIPAA’s general prohibition on disclosing protected health information and describes the exceptions that allow disclosures in specific circumstances. She explains that HIPAA permits disclosures when required by law, including mandated reporting in situations such as abuse or neglect, and in response to court orders, grand jury subpoenas, and civil investigative demands. Claire also notes that disclosures must match the scope of the request and that de-identification may sometimes be appropriate. Jonathan and Claire then discuss HIPAA’s provisions for allowing disclosures to health oversight agencies and situations in which questions arise about how these rules apply. Claire emphasizes the importance of reviewing the language of a CID carefully to determine whether a disclosure fits within HIPAA’s exceptions. Together, they outline factors providers should consider when assessing what information may be produced and how to ensure responses remain within HIPAA’s requirements. They conclude by discussing the value of clear communication between counsel and investigators when questions about HIPAA compliance arise. Jonathan and Claire highlight how proactive dialogue can help clarify expectations and ensure that responses remain consistent with both HIPAA and the scope of the CID. Jonathan Porter | Full Biography Jonathan focuses on white collar criminal defense, federal investigations brought under the False Claims Act, and litigation against the government and whistleblowers, where he uses his experience as a former federal prosecutor to guide clients in sensitive and enterprise-threatening litigation. At the Department of Justice, Jonathan earned a reputation as a top white-collar prosecutor and trial lawyer and was a key member of multiple international healthcare fraud takedowns and high-profile financial crime prosecution teams. He serves as a vice chair of the American Health Law Association’s Fraud and Abuse Practice Group and teaches white collar crime as an adjunct professor of law at Mercer University School of Law. Claire Postman | Full Biography Claire Postman is a senior associate who advises healthcare clients on regulatory compliance and the application of federal and state requirements. Before attending law school, she worked as an analyst researching Medicare and Medicaid policy, which helped shape her interest in translating complex regulations for healthcare stakeholders. Claire assists clients with healthcare regulatory matters and supports organizations involved in transactions such as joint ventures, affiliations, changes of control, and mergers and acquisitions within the healthcare sector. Her background in public health and policy analysis informs her work helping clients understand how evolving regulations apply to their operations.

    19 min
See All (40)

5
out of 5
4 Ratings

About

False Claims Act Insights explores how the U.S. government uses the False Claims Act (FCA) to stamp out fraud and corruption in government contracts. Each episode, Jonathan Porter, a former Assistant U.S. Attorney and currently a partner with Husch Blackwell’s White Collar, Internal Investigations & Compliance team, chats with preeminent guests to provide listeners with an up-to-date understanding of the FCA, including trends in recent litigation and compliance efforts. The show also explores those elements of the FCA that make it a uniquely powerful tool for the government against private business, including the Act’s utilization of whistleblowers and its qui tam provisions, as well as evolving theories of FCA liability that expand the boundaries of what the Act covers, including cybersecurity and so-called reverse FCA claims.

Information

  • Creator
    Jonathan Porter
  • Years Active
    2024 - 2026
  • Episodes
    40
  • Rating
    Clean
  • Copyright
    © 2024 Copyright Husch Blackwell
  • Show Website
    False Claims Act Insights

You Might Also Like